Increase in Pediatric Invasive Group A Streptococcal Infections
December 22, 2022
The Centers for Disease Control and Prevention (CDC) issued a Health Advisory to notify clinicians and public health authorities of a recent increase in pediatric invasive group A streptococcal (iGAS) infections.
Risk of severe hypocalcemia in patients on dialysis receiving denosumab
November 22, 2022
FDA is investigating the risk of severe hypocalcemia with serious outcomes, including hospitalization and death, in patients with advanced
kidney disease on dialysis treated with the osteoporosis medicine denosumab (Prolia®).
Possible increased risk of death, serious side effects with duvelisib (Copiktra)
June 30, 2022
The FDA warns of a possible increased risk of death with the cancer drug, duvelisib (Copiktra) used in the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
COVID-19 Rebound After Paxlovid Treatment
May 25, 2022
The Centers for Disease Control and Prevention (CDC) released a Health Advisory Network (HAN) Health Advisory on the potential for
recurrence of COVID-19 or "COVID-19 rebound."
FDA: Monitor Babies & Young Children Who Receive Injections of Iodine-Containing Contrast Media
March 30, 2022
The FDA recommends that newborns and children through 3 years old have thyroid monitoring within 3 weeks post-injection of iodinated contrast media for medical imaging procedures.
Dental Problems Have Been Reported with Medicines Containing Buprenorphine that are Dissolved in the Mouth
January 12, 2022
The dental problems, including tooth decay, cavities, oral infections, and loss of teeth, can be serious and have been reported even in patients with no history of dental issues.